Condition
Breast Cancer|Colorectal Cancer|Kidney Cancer|Lung Cancer|Malignant Mesothelioma|Pancreatic Cancer
Estimated Enrollment: 40
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Primary Purpose: Treatment
Study ID Numbers: SVMC-ONC-222|CDR0000076913|NCI-V91-0075
Study First Received: November 1, 1999
Last Updated: July 9, 2013
Estimated Primary Completion Date: December 2007
Primary Outcome Measures:
Clinical response (patients with evaluable disease)|Duration of response (patients with evaluable disease)|Survival (patients with evaluable disease)|Time to recurrence (patients without evaluable disease)|Survival (patients without evaluable disease)
Sponsors and Collaborators:
St. Vincent Medical Center – Los Angeles|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00002475
